CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Governance Charles River Laboratories International, Inc.

CRL

US1598641074

Biotechnology & Medical Research

Market Closed - Nyse Other stock markets 01:00:02 15/01/2026 +04			5-day change	1st Jan Change
216.39 ^USD	-1.19%		-0.18%	+8.48%

01-13	Charles River Laboratories International, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 10:30 AM
01-13	Charles River Laboratories International Seeks Acquisitions	CI

Executive Committee: Charles River Laboratories International, Inc.

Manager

Positions heldSince

James Foster

75 year

Chief Executive Officer	01/01/1992
President	01/01/1991

Victoria Creamer

56 year

Human Resources Officer

01/01/2019

Julie Frearson

Chief Tech/Sci/R&D Officer

01/01/2014

Mark Mintz

Chief Tech/Sci/R&D Officer

01/02/2021

Todd Spencer

Investor Relations Contact

01/06/2018

Michael Knell

49 year

Comptroller/Controller/Auditor	26/04/2017
Director of Finance/CFO	29/09/2025

Gina Mullane

Sales & Marketing

01/01/2016

Birgit Girshick

56 year

Chief Operating Officer

11/11/2021

Matthew Daniel

Compliance Officer	01/01/2011
General Counsel	01/01/2011
Corporate Secretary	01/01/2020

Namandje Bumpus

45 year

Chief Tech/Sci/R&D Officer

12/01/2026

Composition of the Board of Directors: Charles River Laboratories International, Inc.

Director

CommitteesSince

James Foster

75 year

Chairman

01/01/2000

Virginia Wilson

70 year

Compensation Committee	01/10/2019
Governance Committee	01/10/2019
Nominating Committee	01/10/2019
Audit Committee Chair
Audit Committee	01/01/2020
Governance Committee Chair

Nancy Andrews

67 year

Governance Committee Chair	20/05/2025
Nominating Committee Chair	20/05/2025
Compensation Committee	01/02/2021

George Llado

60 year

Audit Committee
Governance Committee	16/10/2020
Nominating Committee	16/10/2020

Mark Enyedy

62 year

Audit Committee	27/12/2023
Governance Committee	20/05/2025
Nominating Committee	20/05/2025

Abraham Ceesay

48 year

Audit Committee	28/01/2025
Compensation Committee	10/10/2023

Martin MacKay

69 year

Finance Committee

Reshema Kemps-Polanco

53 year

Compensation Committee Chair

20/05/2025

Steven Barg

64 year

Compensation Committee

20/05/2025

Paul Graves

55 year

Audit Committee

20/05/2025

Craig Thompson

73 year

Director/Board Member	05/12/2022
Independent Dir/Board Member	05/12/2022

Latest Appointments: Charles River Laboratories International, Inc.

01-13	Charles River Laboratories Reports Two Planned Acquisitions; Names Namandje Bumpus as Chief Scientific and Innovation Officer	MT
01-13	Charles River Laboratories Names Dr. Namandjé N. Bumpus as Senior Vice President, Chief Scientific and Innovation Officer	CI
01-08	Charles River Laboratories International, Inc. Announces Chief Executive Officer Changes	CI
01-08	Charles River Laboratories International, Inc. Announces Changes in Board	CI
01-08	Charles River Laboratories International, Chair, President, CEO James Foster to Retire	MT
01-08	Charles River Laboratories announces planned retirement of James C. Foster	RE
15/10/25	Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption	CI

More news

Former Officers and Directors: Charles River Laboratories International, Inc.

Insider

Positions held

SinceUntil

Flavia Pease

Director of Finance/CFO	01/05/2022	29/09/2025
Corporate Officer/Principal	25/04/2022	01/05/2022

Robert Bertolini

Director/Board Member	25/01/2011	20/05/2025
Independent Dir/Board Member	25/01/2011	20/05/2025

Deborah Kochevar

Director/Board Member	29/10/2008	20/05/2025
Independent Dir/Board Member	29/10/2008	20/05/2025

Richard Wallman

Director/Board Member	24/01/2011	20/05/2025
Independent Dir/Board Member	24/01/2011	20/05/2025

George Massaro

Director/Board Member	01/01/2003	20/05/2025
Independent Dir/Board Member	01/01/2003	20/05/2025

William Barbo

Corporate Officer/Principal	01/10/2016	01/01/2025
Sales & Marketing	01/01/2010	01/10/2016

C. Reese

Director/Board Member	03/12/2007	08/05/2024
Independent Dir/Board Member	03/12/2007	08/05/2024

Barbara Patterson

Compliance Officer	01/01/2012	01/12/2023
General Counsel	01/01/2016	01/12/2023

Steven Coen

Comptroller/Controller/Auditor

01/05/2017

01/05/2023

George Milne

Director/Board Member	01/01/2002	10/05/2022
Trading-Equity	01/01/2002	01/01/2002
Independent Dir/Board Member	01/01/2002	10/05/2022

David Smith

Comptroller/Controller/Auditor	31/10/2016	26/04/2017
Director of Finance/CFO	31/10/2016	01/05/2022
Corporate Officer/Principal	01/04/2014	31/10/2016

Christine Pelletier

Human Resources Officer

01/04/2019

01/02/2021

John Kuo

Compliance Officer	01/05/2020	01/09/2020
General Counsel	01/05/2020	01/09/2020
Corporate Secretary	01/05/2020	01/09/2020

David Patrick Johst

Chief Administrative Officer	01/01/1991	31/05/2020
Human Resources Officer	19/04/2010	15/12/2011
General Counsel	15/04/2010	31/05/2020
Corporate Secretary	04/05/2009	31/05/2020

Jean-Paul Mangeolle

Director/Board Member	15/01/2018	06/05/2020
Independent Dir/Board Member	15/01/2018	06/05/2020

Shanna Cotti-Osmanski

Chief Tech/Sci/R&D Officer

01/01/2006

01/01/2020

Davide A. Molho

Chief Operating Officer	13/02/2018	02/08/2018
Corporate Officer/Principal	03/07/2009	13/02/2018
President	13/02/2018	02/08/2018

Susan E. Hardy

Investor Relations Contact

31/05/2018

Grace Lee

Human Resources Officer

01/01/2016

01/01/2018

John Crowley

Comptroller/Controller/Auditor

30/09/2013

01/11/2016

Nancy A. Gillett

Chief Tech/Sci/R&D Officer	24/08/2011	07/03/2016
Corporate Officer/Principal	01/09/1999	24/08/2011

Thomas Ackerman

Director of Finance/CFO	01/01/1996	12/08/2015
Corporate Officer/Principal	01/01/1992	01/01/1996

Arthur Hubbs

Chief Tech/Sci/R&D Officer	01/05/2010	01/08/2015
Chief Tech/Sci/R&D Officer	01/01/2020	-

Emily Hickey

Corporate Officer/Principal

01/10/2013

William H. Waltrip

Director/Board Member	01/01/1996	07/05/2013
Director of Research - Equity	01/01/1996	01/01/1996
Independent Dir/Board Member	01/01/1996	07/05/2013

Samuel O. Thier

Director/Board Member	01/01/2000	07/05/2013
Independent Dir/Board Member	01/01/2000	07/05/2013

Nancy Chang

Director/Board Member

24/10/2007

24/01/2011

Real H. Renaud

Corporate Officer/Principal

01/01/1964

31/12/2010

Cheri Walker

Corporate Officer/Principal

01/04/2007

Stephanie B. Wells

Sales & Marketing

12/03/2007

Nicholas Ventresca

Chief Tech/Sci/R&D Officer

01/04/2006

Stephen K. Durham

Corporate Officer/Principal

04/01/2011

David J. Elliott

Comptroller/Controller/Auditor

01/10/2005

Robert Cawthorn

Director/Board Member

01/01/1999

25/02/2005

S. Louise McCrary

Director/Board Member

25/02/2005

John Urquhart

Director/Board Member

01/01/2004

01/01/2005

Joanne P. Acford

General Counsel	01/12/2004	-
Corporate Secretary	01/12/2004	-

Christopher J. Perkin

Corporate Officer/Principal

01/10/2004

Linda McGoldrick

Director/Board Member

01/01/2004

Joseph C. Siglin

Corporate Officer/Principal

04/01/2011

Douglas E. Rogers

Director/Board Member	01/01/1999	01/01/2001
Director/Board Member	04/05/2009	24/01/2011

Stephen D. Chubb

Director/Board Member	01/01/1994	-
Independent Dir/Board Member	01/01/1994	-

Jörg M. Geller

Corporate Officer/Principal

01/01/1986

John Beattie

Corporate Officer/Principal

Susan Desmond

Corporate Officer/Principal

Dennis R. Shaughnessy

General Counsel	-	-
Corporate Secretary	-	-

John Montana

Corporate Officer/Principal

William H. Eagan

Treasurer

01/01/2007

Joel McComb

Corporate Officer/Principal

Thompson Dean

Director/Board Member

Walter S. Nimmo

Director/Board Member

Michael F. Ankcorn

Corporate Officer/Principal

Alastair Stuart McEwan

Corporate Officer/Principal

Karen A. Blomquist

Public Communications Contact

Andy Self

Corporate Officer/Principal

Kitty Sahin

Corporate Officer/Principal

Henry L. Foster

Founder

01/01/1947

Age distribution of managers

Parity Men Women

Male	20
Female	8

Of which Executive Committee

Male	7
Female	3

Of which Directors

Male	9
Female	2

Revisions

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Charles River Laboratories International, Inc. specializes in the development of products and services in the field of research and non-clinical drug development for pharmaceutical companies, government agencies and academic institutions. Net sales break down by activity as follows: - discovery and safety assessment services (60.5%): discovery services for the identification, screening and selection of main compounds for the development of new drug candidates, and in vivo and in vitro testing, including pharmacokinetic, bioanalytical, metabolic, toxicological and pathological studies, for the safety assessment of pharmaceutical products, medical devices, animal health products, chemical and agrochemical products and biocides; - development and sale of research models and related services (20.5%): mice, rats, immunodeficient models, rabbits, guinea pigs, hamsters, etc. The group also offers primary cells and specialized products (bioconservation products, freezing media for cell cultures, antigens, peptides, humanized mouse models, etc.) for the development and manufacture of new cell therapies ; - development of solutions used in drug manufacturing processes (19%): products and services for microbiological testing, in vitro testing, endotoxin testing, microbial identification, development, manufacturing of avian vaccines, etc. The group also offers contract manufacturing services for cell and gene therapies. Net sales break down by source of income between sales of services (81.6%) and sales of products (18.4%). Net sales are distributed geographically as follows: the United States (55.3 Europe (26.6%), Canada (11.9%), Asia/Pacific (4.9%) and other (1.3%).

Employees

19,400

Sector

Biotechnology & Medical Research

Calendar

02-18 - Q4 2025 Earnings Release (Projected)

More about the company

Governance Charles River Laboratories International, Inc.

Equities

CRL

US1598641074

Biotechnology & Medical Research

Executive Committee: Charles River Laboratories International, Inc.

Composition of the Board of Directors: Charles River Laboratories International, Inc.

Latest Appointments: Charles River Laboratories International, Inc.

Former Officers and Directors: Charles River Laboratories International, Inc.

Age distribution of managers

Parity Men Women

Revisions

ESG MSCI

Company Profile